Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2515-2522

  Hsieh, Ya Ju ^a   Ke, Chien Chih ^b,c   Liu, Ren Shyan ^a,b,c   Wang, Fu Hui ^b,c   Tang, Kam Tsun ^b   Chi, Chin Wen ^a   Chen, Fu Du ^d   Lee, Chen Hsen ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NRPGM   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Anaplastic thyroid cancer; ARO cells; Mouse model; Radioiodide imaging; SCID; Severe combined immune deficiency; Sodium iodide symporter; Xenograft

Indexed keywords

COMPLEMENTARY DNA; IODINE 125; IODINE 131; SODIUM IODIDE SYMPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CELL MEMBRANE; CONTROLLED STUDY; DRUG HALF LIFE; DRUG UPTAKE; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; MICE; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYMPORTERS; THYROID NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 34547823565     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schmutzler C and Koehrle J: Innovative strategies for the treatment of thyroid cancer. Eur J Endocrinol 143: 15-24, 2000.
2. Beierwaltes WH: The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 8: 79-94, 1979.
3. Pasieka, JL: Anaplastic thyroid cancer. Current opinion in oncology 15: 78-83, 2003.
4. Giuffrida D and Gharib H: Anaplastic thyroid carcinoma: Current diagnosis and treatment. Ann Oncol 11: 1083-1089, 2000.
5. Dai G, Levy O and Carrasco N: Cloning and characterization of the thyroid iodide transporter. Nature 379: 458-460, 1996.
6. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL and Jhiang SM: Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 226: 339-345, 1996.
7. Smanik PA, Ryu KY, Theil KS, Mazzaferri EL and Jhiang SM: Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinol 138: 3555-3558, 1997.
8. - symporter (NIS): Recent advances. J Bioenerg Biomembr 30: 195-206, 1998.
9. - symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol 213: 59-70, 2003.
10. - symporter. Mechanism, stoichiometry, and specificity. J Biol Chem 272: 27230-27238, 1997.
11. Boland A, Ricard M, Opolon P, Bidart JM, Yeh P, Filetti S, Schlumberger M and Perricaudet M: Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 60: 3484-3492, 2000.
12. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ and Morris JC: In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Clin Cancer Res 11: 1483-1489, 2005.
13. - symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther 7: 740-749, 2000.
14. Sieger S, Jiang S, Schonsiegel F, Eskerski H, Kubler W, Altmann A and Haberkorn U: Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3). Eur J Nucl Med Mol Imaging 30: 748-756, 2003.
15. Haberkorn U, Kinscherf R, Kissel M, Kubler W, Mahmut M, Sieger S, Eisenhut M, Peschke P and Altmann A: Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Ther 10: 774-780, 2003.
16. Dwyer RM, Schatz SM, Bergert ER, Myers RM, Harvey ME, Classic KL, Blanco MC, Frisk CS, Marler RJ, Davis BJ, O'Connor MK, Russell SJ and Morris JC: A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer. Mol Ther 12: 835-841, 2005.
17. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY and Morris JC: Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 60: 6526-6530, 2000.
18. Huang M, Batra RK, Kogai T, Lin YQ, Hershman JM, Lichtenstein A, Sharma S, Zhu LX, Brent GA and Dubinett SM: Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther 8: 612-618, 2001.
19. Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC and Russell SJ: Genetically targeted radiotherapy for multiple myeloma. Blood 102: 489-496, 2003.
20. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ and Morris JC: Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther 13: 60-66, 2006.
21. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ and Morris JC: Adenovirus-mediated and targeted expression of the sodium/iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum Gene Ther 17: 661-668, 2006.
22. hen L, Altmann A, Mier W, Eskerski H, Leotta K, Guo L, Zhu R and Haberkorn U: Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene. J Nucl Med 47(5): 854-862, 2006.
23. - symporter gene. Endocrinol 138: 4493-4496, 1997.
24. Lee YJ, Chung JK, Shin JH, Kang JH, Jeong JM, Lee DS and Lee MC: In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene. Thyroid 14: 889-895, 2004.
25. Weiss SJ, Philip NJ and Grollmann EF: Iodine transport in a continuous line of cultured cells from rat thyroid. Endocrinology 114: 1090-1098, 1984.
26. Shin JH, Chung JK, Kang JH, Lee YJ, Kim KI, So Y, Jeong JM, Lee DS and Lee MC: Noninvasive imaging for monitoring of viable cancer cells using a dual-imaging reporter gene. J Nucl Med 45: 2109-2115, 2004.
27. Jackson RJ and Kaminski A: Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1: 985-1000, 1995.
28. - symporter of the rat. Clin Immunol Immunopath 89: 271-278, 1998.
29. null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 164: 2496-2507, 2000.